Search

Your search keyword '"Moosmann, Nicolas"' showing total 5 results
Start Over Author "Moosmann, Nicolas" Language german
5 results on '"Moosmann, Nicolas"'

3. [Colon cancer: adjuvant chemotherapy and aftercare].

Author

Heinemann V, Giessen C, Modest D, Moosmann N, and Stintzing S

Subjects
Aftercare, Antineoplastic Combined Chemotherapy Protocols adverse effects, Chemotherapy, Adjuvant, Colonic Neoplasms mortality, Colonic Neoplasms pathology, Combined Modality Therapy, Germany, Guideline Adherence, Humans, Neoplasm Recurrence, Local diagnosis, Neoplasm Recurrence, Local prevention & control, Neoplasm Staging, Survival Rate, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Colonic Neoplasms drug therapy, Colonic Neoplasms surgery
Published
2011

4. [Neoadjuvant and adjuvant therapies for solid tumours].

Author

Heinemann V and Moosmann N

Subjects
Breast Neoplasms drug therapy, Breast Neoplasms surgery, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung pathology, Carcinoma, Non-Small-Cell Lung radiotherapy, Carcinoma, Non-Small-Cell Lung surgery, Colonic Neoplasms drug therapy, Colonic Neoplasms pathology, Colonic Neoplasms surgery, Endometrial Neoplasms drug therapy, Endometrial Neoplasms pathology, Endometrial Neoplasms radiotherapy, Endometrial Neoplasms surgery, Esophageal Neoplasms drug therapy, Esophageal Neoplasms radiotherapy, Esophageal Neoplasms surgery, Female, Humans, Informed Consent, Lung Neoplasms drug therapy, Lung Neoplasms pathology, Lung Neoplasms radiotherapy, Lung Neoplasms surgery, Male, Neoplasm Recurrence, Local prevention & control, Neoplasm Staging, Neoplasms drug therapy, Neoplasms radiotherapy, Neoplasms surgery, Ovarian Neoplasms drug therapy, Ovarian Neoplasms pathology, Ovarian Neoplasms surgery, Pancreatic Neoplasms drug therapy, Pancreatic Neoplasms surgery, Prognosis, Prostatic Neoplasms drug therapy, Prostatic Neoplasms pathology, Prostatic Neoplasms surgery, Rectal Neoplasms drug therapy, Rectal Neoplasms pathology, Rectal Neoplasms radiotherapy, Rectal Neoplasms surgery, Risk Factors, Stomach Neoplasms drug therapy, Stomach Neoplasms pathology, Stomach Neoplasms surgery, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms surgery, Chemotherapy, Adjuvant, Neoadjuvant Therapy adverse effects, Neoplasms therapy, Radiotherapy, Adjuvant
Abstract

Today adjuvant or neoadjuvant therapies are standard treatment for many types of cancer. Chemotherapy, radiotherapy, hormone therapy or immunotherapy applied before, during or after an operation can lower the risk of relapse and hence, increase the chances of a cure. After neoadjuvant therapy, frequently the organ does not have to be removed in the subsequent operation. Depending on the risk of relapse, adjuvant therapies are employed after due consideration of benefit, risk and duration of treatment. In ongoing clinical studies, the possibilities of influencing the effect of epidermal growth factor (EGF) as well as vascular endothelial growth factor (VEGF) are being investigated.

Published
2007

5. [Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?].

Author

Moosmann N, Boeck S, and Heinemann V

Subjects
Adenocarcinoma drug therapy, Adenocarcinoma pathology, Adenocarcinoma radiotherapy, Adenocarcinoma surgery, Combined Modality Therapy, Gastrointestinal Neoplasms pathology, Gastrointestinal Neoplasms radiotherapy, Gastrointestinal Neoplasms surgery, Humans, Lymphatic Metastasis pathology, Male, Middle Aged, Neoplasm Staging, Radiotherapy, Adjuvant, Rectal Neoplasms drug therapy, Rectal Neoplasms pathology, Rectal Neoplasms radiotherapy, Rectal Neoplasms surgery, Survival Rate, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Gastrointestinal Neoplasms drug therapy, Neoadjuvant Therapy
Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results